Novel Drug May Improve Daily Activities in ET: Phase 3 Trial

04 Nov 2026 0 comments

Ulixacaltamide is associated with significantly greater improvement than placebo in all 12 activities of daily living domains assessed in patients with essential tremor in new research.
Medscape Medical News

Source: Medscape Neurology Published 04 Nov 2026 Imported 04 Nov 2026 Relevancy: Not reviewed

Read the article

Comments

No comments yet.

Unrestricted

All comments are reviewed before being published. Most comments are approved unless they are clearly inappropriate or unsafe.

Comments

Leave a comment